Design considerations, architecture, and use of the Mini-Sentinel distributed data system - PubMed (original) (raw)
. 2012 Jan:21 Suppl 1:23-31.
doi: 10.1002/pds.2336.
Affiliations
- PMID: 22262590
- DOI: 10.1002/pds.2336
Design considerations, architecture, and use of the Mini-Sentinel distributed data system
Lesley H Curtis et al. Pharmacoepidemiol Drug Saf. 2012 Jan.
Abstract
Purpose: We describe the design, implementation, and use of a large, multiorganizational distributed database developed to support the Mini-Sentinel Pilot Program of the US Food and Drug Administration (FDA). As envisioned by the US FDA, this implementation will inform and facilitate the development of an active surveillance system for monitoring the safety of medical products (drugs, biologics, and devices) in the USA.
Methods: A common data model was designed to address the priorities of the Mini-Sentinel Pilot and to leverage the experience and data of participating organizations and data partners. A review of existing common data models informed the process. Each participating organization designed a process to extract, transform, and load its source data, applying the common data model to create the Mini-Sentinel Distributed Database. Transformed data were characterized and evaluated using a series of programs developed centrally and executed locally by participating organizations. A secure communications portal was designed to facilitate queries of the Mini-Sentinel Distributed Database and transfer of confidential data, analytic tools were developed to facilitate rapid response to common questions, and distributed querying software was implemented to facilitate rapid querying of summary data.
Results: As of July 2011, information on 99,260,976 health plan members was included in the Mini-Sentinel Distributed Database. The database includes 316,009,067 person-years of observation time, with members contributing, on average, 27.0 months of observation time. All data partners have successfully executed distributed code and returned findings to the Mini-Sentinel Operations Center.
Conclusion: This work demonstrates the feasibility of building a large, multiorganizational distributed data system in which organizations retain possession of their data that are used in an active surveillance system.
Copyright © 2012 John Wiley & Sons, Ltd.
Similar articles
- The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
Platt R, Carnahan RM, Brown JS, Chrischilles E, Curtis LH, Hennessy S, Nelson JC, Racoosin JA, Robb M, Schneeweiss S, Toh S, Weiner MG. Platt R, et al. Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:1-8. doi: 10.1002/pds.2343. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262586 - The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R, Reichman ME, Midthun K, Woodcock J. Robb MA, et al. Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:9-11. doi: 10.1002/pds.2311. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262587 No abstract available. - A policy framework for public health uses of electronic health data.
McGraw D, Rosati K, Evans B. McGraw D, et al. Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:18-22. doi: 10.1002/pds.2319. Pharmacoepidemiol Drug Saf. 2012. PMID: 22262589 - Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. Trifirò G, et al. J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159. J Intern Med. 2014. PMID: 24635221 Review. - A review of complications associated with vertebroplasty and kyphoplasty as reported to the Food and Drug Administration medical device related web site.
Nussbaum DA, Gailloud P, Murphy K. Nussbaum DA, et al. J Vasc Interv Radiol. 2004 Nov;15(11):1185-92. doi: 10.1097/01.RVI.0000144757.14780.E0. J Vasc Interv Radiol. 2004. PMID: 15525736 Review.
Cited by
- Application of the U.S. Food and Drug Administration's Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model-formatted National Health Insurance Research Database.
Lin FJ, Huang LY, Wang CC, Toh S. Lin FJ, et al. J Food Drug Anal. 2023 Dec 15;31(4):772-781. doi: 10.38212/2224-6614.3482. J Food Drug Anal. 2023. PMID: 38526825 Free PMC article. - Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States.
Lo Re Iii V, Cocoros NM, Hubbard RA, Dutcher SK, Newcomb CW, Connolly JG, Perez-Vilar S, Carbonari DM, Kempner ME, Hernández-Muñoz JJ, Petrone AB, Pishko AM, Rogers Driscoll ME, Brash JT, Burnett S, Cohet C, Dahl M, DeFor TA, Delmestri A, Djibo DA, Duarte-Salles T, Harrington LB, Kampman M, Kuntz JL, Kurz X, Mercadé-Besora N, Pawloski PA, Rijnbeek PR, Seager S, Steiner CA, Verhamme K, Wu F, Zhou Y, Burn E, Paterson JM, Prieto-Alhambra D. Lo Re Iii V, et al. Clin Epidemiol. 2024 Feb 10;16:71-89. doi: 10.2147/CLEP.S448980. eCollection 2024. Clin Epidemiol. 2024. PMID: 38357585 Free PMC article. - Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial.
Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Singh S, et al. PLoS One. 2024 Feb 12;19(2):e0297562. doi: 10.1371/journal.pone.0297562. eCollection 2024. PLoS One. 2024. PMID: 38346025 Free PMC article. - Factors Influencing the Acceptance of Distributed Research Networks in Korea: Data Accessibility and Data Security Risk.
Park J, Rho MJ. Park J, et al. Healthc Inform Res. 2023 Oct;29(4):334-342. doi: 10.4258/hir.2023.29.4.334. Epub 2023 Oct 31. Healthc Inform Res. 2023. PMID: 37964455 Free PMC article. - Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simple.
Cocoros NM, Gurwitz JH, Cziraky MJ, Granger CB, Harkins T, Haynes K, Li X, Parlett L, Seeger JD, Singh S, McMahill-Walraven CN, Platt R. Cocoros NM, et al. Clin Trials. 2023 Aug;20(4):416-424. doi: 10.1177/17407745231160459. Epub 2023 Jun 15. Clin Trials. 2023. PMID: 37322894 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials